Harrow Health Stock Beta
| HROW Stock | USD 38.08 1.94 4.85% |
Harrow Health fundamentals help investors to digest information that contributes to Harrow Health's financial success or failures. It also enables traders to predict the movement of Harrow Stock. The fundamental analysis module provides a way to measure Harrow Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Harrow Health stock.
Harrow | Beta |
Harrow Health Company Beta Analysis
Harrow Health's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Harrow Health Beta | 0.76 |
Most of Harrow Health's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Harrow Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Harrow Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Harrow Health is extremely important. It helps to project a fair market value of Harrow Stock properly, considering its historical fundamentals such as Beta. Since Harrow Health's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Harrow Health's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Harrow Health's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Harrow Health has a Beta of 0.763. This is 11.28% lower than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The beta for all United States stocks is notably lower than that of the firm.
Harrow Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Harrow Health's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Harrow Health could also be used in its relative valuation, which is a method of valuing Harrow Health by comparing valuation metrics of similar companies.Harrow Health is currently under evaluation in beta category among its peers.
Harrow Health Current Valuation Drivers
We derive many important indicators used in calculating different scores of Harrow Health from analyzing Harrow Health's financial statements. These drivers represent accounts that assess Harrow Health's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Harrow Health's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 197.0M | 177.6M | 231.2M | 405.3M | 365.3M | 383.6M | |
| Enterprise Value | 213.3M | 197.1M | 267.0M | 413.2M | 481.7M | 505.8M |
Harrow Health ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Harrow Health's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Harrow Health's managers, analysts, and investors.Environmental | Governance | Social |
Harrow Health Institutional Holders
Institutional Holdings refers to the ownership stake in Harrow Health that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Harrow Health's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Harrow Health's value.| Shares | Nuveen Asset Management, Llc | 2024-09-30 | 328.9 K | First Turn Management Llc | 2024-09-30 | 326.6 K | Rice Hall James & Associates, Llc | 2024-09-30 | 314.9 K | Northern Trust Corp | 2024-09-30 | 296.8 K | Renaissance Technologies Corp | 2024-09-30 | 293.8 K | Deutsche Bank Ag | 2024-06-30 | 284 K | Charles Schwab Investment Management Inc | 2024-09-30 | 251.6 K | Jpmorgan Chase & Co | 2024-09-30 | 238.4 K | Voloridge Investment Management, Llc | 2024-09-30 | 215.7 K | Opaleye Management Inc | 2024-09-30 | 4 M | Private Capital Management, Llc | 2024-09-30 | 2.2 M |
As returns on the market increase, Harrow Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Harrow Health is expected to be smaller as well.
Harrow Fundamentals
| Return On Equity | -0.5 | ||||
| Return On Asset | -0.0168 | ||||
| Profit Margin | (0.20) % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 1.61 B | ||||
| Shares Outstanding | 35.61 M | ||||
| Shares Owned By Insiders | 14.11 % | ||||
| Shares Owned By Institutions | 59.17 % | ||||
| Number Of Shares Shorted | 2.51 M | ||||
| Price To Earning | 24.45 X | ||||
| Price To Book | 25.71 X | ||||
| Price To Sales | 8.43 X | ||||
| Revenue | 130.19 M | ||||
| Gross Profit | 63.21 M | ||||
| EBITDA | 9.72 M | ||||
| Net Income | (24.41 M) | ||||
| Cash And Equivalents | 51.7 M | ||||
| Cash Per Share | 1.91 X | ||||
| Total Debt | 190.5 M | ||||
| Current Ratio | 5.01 X | ||||
| Book Value Per Share | 1.64 X | ||||
| Cash Flow From Operations | 3.84 M | ||||
| Short Ratio | 3.76 X | ||||
| Earnings Per Share | (0.95) X | ||||
| Price To Earnings To Growth | (2.50) X | ||||
| Target Price | 60.85 | ||||
| Number Of Employees | 315 | ||||
| Beta | 0.76 | ||||
| Market Capitalization | 1.43 B | ||||
| Total Asset | 312.16 M | ||||
| Retained Earnings | (133.9 M) | ||||
| Working Capital | 90.14 M | ||||
| Current Asset | 8.77 M | ||||
| Current Liabilities | 2.56 M | ||||
| Net Asset | 312.16 M |
About Harrow Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Harrow Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Harrow Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Harrow Health based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Harrow Stock Analysis
When running Harrow Health's price analysis, check to measure Harrow Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Harrow Health is operating at the current time. Most of Harrow Health's value examination focuses on studying past and present price action to predict the probability of Harrow Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Harrow Health's price. Additionally, you may evaluate how the addition of Harrow Health to your portfolios can decrease your overall portfolio volatility.